Atia Vision Stock

www.atiavision.comHealthcareFounded: 2022

Atia Vision offers a solution to sufferers of cataracts through its Modular Presbyopia Correcting Intraocular Lens (IOL). Atia Vision is a highly-specialized medical hub for this product, and controls the supply and go-to-market lifecycle that reaches healthcare providers. Through Atia Vision's product research and development, it seeks healthier and safer outcomes for the patients it serves.

Register for Details

For more details on financing and valuation for Atia Vision, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Atia Vision.

Register Today

Team

Management Team

Miriam Maghribi
President & Chief Executive Officer
David Voris
Chief Executive Officer
Debbie White
Senior Vice President, Human Resources
Robert Edesess
Vice President, Intellectual Property
Melissa Guerrero
Senior Director of Quality Assurance
Claudio Argento
Chief Technology Officer

Board Members

Amr Salahieh
ShifaMed
Bihua Chen
Cormorant Asset Management
Casey Gordon
The Capital Partnership
Henry Chen
Delos Capital

Other companies like Atia Vision in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM

News

Atia Vision, committed to improving patient outcomes through the development of a modular presbyopia-correcting intraocular lens (IOL), announced today the first close of a $42M Series E financing.